This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Comerica Lawsuit Against Bombardier Gets Dismissed Yet Again
by Zacks Equity Research
Per the judge's ruling, Comerica (CMA) will not be able to file an amended complaint.
Raymond James Fined $15M for Charging Fee on Inactive Accounts
by Zacks Equity Research
Raymond James (RJF) agrees to pay $15 million for wrongfully charging fees from clients on inactive retail accounts.
Lloyds Agrees to Acquire Tesco Bank's Mortgage Portfolio
by Zacks Equity Research
Lloyds (LYG) agrees to buy the residential mortgage portfolio of Tesco Personal Finance plc.
Near-Term Prospects for Investment Bank Industry Appear Gloomy
by Priti Dhanuka
Volatility-driven trading revenues and slowdown in investment banking activities to keep profitability subdued for investment banks in the quarters ahead.
Raymond James (RJF) Q3 Earnings Miss, Expenses Increase Y/Y
by Zacks Equity Research
Muted investment banking and higher operating expenses hurt Raymond James' (RJF) fiscal Q3 earnings.
What's in the Offing for Raymond James (RJF) in Q3 Earnings?
by Zacks Equity Research
Slight improvement in advisory fees and muted growth in underwriting income are expected to influence Raymond James' (RJF) fiscal Q3 earnings.
E*TRADE (ETFC) Q2 Earnings Beat Estimates, DARTs Improve
by Zacks Equity Research
E*TRADE's (ETFC) Q2 performance displays a rise in net interest income, a benefit to provision for loan losses and improved DARTs, partly muted by fall in fee income and higher expenses.
Raymond James (RJF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Raymond James (RJF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Schwab (SCHW) Q2 Earnings & Revenues Match, Expenses Rise
by Zacks Equity Research
Relatively high interest rates and growth in total client assets aid Schwab's (SCHW) Q2 earnings. However, increase in operating costs is a headwind.
Piper Jaffray Inks Deal to Acquire Sandler O'Neill for $485M
by Zacks Equity Research
Piper Jaffray's (PJC) acquisition of Sandler O'Neill will be earnings accretive and expand its M&A business.
Online Brokers Down on Disappointing Near-Term Prospects
by Swayta Shah
Prospects of online brokers - Schwab (SCHW), TD Ameritrade (AMTD) and E*TRADE (ETFC) - look dismal due to a number of factors that are weighing on investors' sentiments.
5 Reasons That Make Piper Jaffray (PJC) Investment Worthy
by Swayta Shah
Piper Jaffray (PJC) stock is worth considering now, given its solid prospects and favorable operating backdrop.
Stifel Inks Deal to Acquire GMP's Capital Markets Business
by Zacks Equity Research
In a bid to fortify its investment banking business and establish foothold in Canada, Stifel Financial (SF) seals deal to buy capital markets business of Toronto-based GMP Capital.
Is Raymond James (RJF) a Great Pick for Value Investors Now?
by Zacks Equity Research
Let's see if Raymond James (RJF) stock is a good choice for value-oriented investors right now from multiple angles.
Here's Why it is Wise to Hold on to Goldman (GS) Stock Now
by Zacks Equity Research
Cost-saving measures and diversified product portfolio support Goldman (GS). However, litigation issues pose a headwind.
Morgan Stanley (MS) Slashes Six Equity Business Jobs in Asia
by Zacks Equity Research
Due to year-over-year decline in equity trading revenues in first-quarter 2019, Morgan Stanley (MS) is cutting jobs at its equities business in Asia.
Is Raymond James (RJF) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is Raymond James (RJF) Down 6.1% Since Last Earnings Report?
by Zacks Equity Research
Raymond James (RJF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
E*TRADE (ETFC) Up 8.6% YTD: Will the Stock Rally Further?
by Zacks Equity Research
E*TRADE Financial (ETFC) climbs 8.6% year to date compared with the industry's growth of 9.1%.
5 Reasons to Include Stifel Financial (SF) in Your Portfolio
by Zacks Equity Research
Stifel Financial's (SF) revenue growth, efforts to diversify product offerings and projected earnings growth rate reflect its upside potential.
Goldman's (GS) Ratings and Outlook Reiterated by Moody's
by Zacks Equity Research
Goldman's (GS) ratings and outlook affirmation by Moody's reflects its solid prospects.
Should Value Investors Buy Raymond James (RJF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Raymond James to Expand Wealth Management Business in Canada
by Zacks Equity Research
Raymond James' (RJF) plan to expand wealth management operation in Canada will go a long way in supporting its financials.
Reasons to Hold On to E*TRADE Financial (ETFC) Stock Now
by Zacks Equity Research
Though escalating expenses remains a concern, E*TRADE Financial's (ETFC) strategic initiatives along with rising interest rates will support the company in the near term.
Zacks.com featured highlights include: PepsiCo, Raymond James, Kansas City Southern, Fortive and Abbott Laboratories
by Zacks Equity Research
Zacks.com featured highlights include: PepsiCo, Raymond James, Kansas City Southern, Fortive and Abbott Laboratories